GTHX

G1 Therapeutics, Inc.

3.16 USD
+0.02 (+0.64%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

G1 Therapeutics, Inc. stock is up 135.82% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 6 December’s closed higher than November. In the last 4 Unusual Options Trades, there were 3 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
19 Oct 14:56 19 Apr, 2024 2.50 CALL 700 6203
21 Nov 20:57 19 Apr, 2024 2.50 CALL 3100 9626
28 Nov 18:23 19 Apr, 2024 2.50 CALL 1300 10148
08 Dec 17:30 19 Jul, 2024 5.00 PUT 100 15

About G1 Therapeutics, Inc.

G1 Therapeutics, Inc. engages in the discovery, development, and commercialization of small molecule therapeutics. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients. It is also developing trilaciclib, a (CDK) 4/6 inhibitor that is in Phase III clinical trials for patients with first line colorectal cancer; and rintodestrant, an oral selective estrogen receptor degrader.